Rutendo Kuwana, the WHO team lead for incidents with substandard...
Category:
Health
Latest
IMA calls for protection of health workers
"This is the need of the hour. How can a doctor treat a critical...
Lighting gas stoves found to raise indoor benzene above that in secondhand smoke
“Benzene forms in flames and other high-temperature environments,...
European hunt for assets for Chinese assets in insurance, healthcare and automobile sector
“These are the major growth areas with massive amounts of investments. EU companies are pretty keen to get a piece of the action,” said Alan Wang, Partner at law firm Freshfields Bruckhaus Deringer.
“The EU-China Comprehensive Agreement on Investment (CAI) will certainly facilitate the FDI, including M&A, by EU investors into China,” said Cherrie Shi, a senior counsel at law firm FenXun Partners, Baker McKenzie’s Joint Operation partner.
Total M&A value of EU companies into China amounted to $71 billion for the past three decades, much lower than the $117 billion recorded over the same period from American companies, data from Refinitiv showed.
India to continue export of medicines, including vaccines: PM Modi
India is the world’s biggest vaccine maker. Its pharmaceutical industry has been freeing up capacity and pushing ahead with investments to help support a global vaccination campaign.
Health secretary Rajesh Bhushan earlier this month said there was no ban on vaccine exports, following media reports that the government had imposed restrictions to ensure domestic vaccine requirements were met first.
India to start COVID-19 vaccination drive from January 16, 3 cr healthcare, frontline workers to get shots first
After healthcare and frontline workers, the vaccines will be given to “those above 50 years of age and the under-50 population groups with co-morbidities, numbering around 2.7 million,” the statement said.
India’s drug regulator has approved two coronavirus vaccines for emergency use, Covishield, developed by AstraZeneca and Oxford University and Covaxin by local company Bharat Biotech and a state-run institute.
COVID-19 impact: 8.7 lakh expats returned to Kerala, over half of them due to job loss: Official Data
The data from the Non-Resident Keralites Affairs (NORKA) department as of Thursday also showed that 1,11,151 of the 13,27,330 Keralites who came back from other parts of the country also cited loss of jobs as the reason for their return. The second biggest reason cited by the returnees (2.08 lakh) was their job visas. The rest include senior citizens, or children, and family members of expats.
“We should be able to give Covid-19 vaccines to our countrymen soon”: Vardhan
The dry run is aimed at testing the laid out mechanisms for COVID-19 vaccination roll-out in the health system and to assess operational feasibility of using Co-WIN application in a field environment for planning, implementation, and reporting at the block, district, and state level.
Up to 4,000 financial firms could fail due to COVID, says UK regulator
“At end of October we’ve identified there are 4,000 financial services firms with low financial resilience and at heightened risk of failure,” said Sheldon Mills, the FCA’s executive director of consumers and competition.
“These are predominantly small and medium sized firms and approximately 30% have the potential to cause harm in failure.”
U.S. considering adding Alibaba, Tencent to China investment ban
Some investors expressed skepticism, however, that Alibaba and Tencent would face long-term restrictions – given that they are worth a combined $1.3 trillion, widely held by U.S. investors and the likely reputational and financial hit to U.S. stock markets.
Protective immunity against novel coronavirus may last for over eight months: Study
The study, published in the journal Science, helps clarify some concerning data from other institutes, which showed a dramatic drop-off of COVID-fighting antibodies in the months following infection. Some feared that this decline in antibodies meant that the body wouldn’t be equipped to defend itself against reinfection.
Severe allergic reactions reported in the US after getting COVID-19 vaccine, but CDC says cases are rare
The Centers for Disease Control and Prevention said early safety monitoring has detected 21 cases of anaphylaxis, a severe allergic reaction, after receiving the Pfizer-BioNTech COVID-19 vaccine.
Anaphylaxis is a serious, life-threatening allergic reaction and requires immediate medical attention, according to the American Academy of Allergy Asthma & Immunology. Symptoms can include skin rash, nausea, vomiting, difficulty breathing and shock. The most common anaphylactic reactions are to foods, insect stings, medication and latex.
Loan repay demand by official is not abetment to suicide: HC
the demand of outstanding loan amount from the person who was in default of payment of loan amount, during the course of employment as a duty, at any stretch of imagination cannot be said to be any intention to aid or to instigate or to abet the deceased to commit suicide,” HC said
There have some cases recently in Telangana of people reportedly ending their lives after they were harassed to pay back loans given in alleged violations of regulatory guidelines to gullible and needy victims facing economic hardships,